Ventum Financial set a C$10.00 target price on 5N Plus (TSE:VNP – Free Report) in a research note issued to investors on Thursday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
VNP has been the topic of several other reports. National Bankshares boosted their price target on 5N Plus from C$8.00 to C$8.50 in a research note on Tuesday, November 5th. Desjardins lifted their price objective on 5N Plus from C$7.25 to C$8.50 and gave the stock a “buy” rating in a report on Tuesday, September 10th. Finally, Raymond James upped their target price on 5N Plus from C$7.50 to C$8.50 in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy” and a consensus target price of C$8.60.
Read Our Latest Analysis on 5N Plus
5N Plus Stock Down 2.0 %
Insider Activity
In other 5N Plus news, Director Jean-Marie Bourassa bought 9,000 shares of the stock in a transaction dated Friday, November 15th. The stock was bought at an average cost of C$6.75 per share, for a total transaction of C$60,750.00. 4.91% of the stock is currently owned by corporate insiders.
About 5N Plus
5N Plus Inc produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells.
Read More
- Five stocks we like better than 5N Plus
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Invest in the FAANG Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for 5N Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 5N Plus and related companies with MarketBeat.com's FREE daily email newsletter.